About
Biologics
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
9
As Collaborator
6
Total Enrollment
4,289
By Phase
PHASE2: 2PHASE1/PHASE2: 3PHASE1: 7PHASE3: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 7TERMINATED: 6NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07036380Collaborator
MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
PHASE2Not yet recruiting
75 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2029
NCT05673057Lead Sponsor
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
249 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2029
NCT05098405Lead Sponsor
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
PHASE1Terminated
46 participants
Started: Oct 11, 2021 · Completed: Jan 19, 2024
NCT05780463Collaborator
MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
PHASE3Completed
485 participants
Started: Jun 11, 2021 · Completed: Jun 8, 2023
NCT04828161Collaborator
A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
PHASE2/PHASE3Terminated
407 participants
Started: May 10, 2021 · Completed: Jan 27, 2022
Funding History (1)
DRS
Mar 15, 2021
Locations (1)
Headquarters
Zurich, Switzerland
Map
Loading map...